Showing results (81-90 of 313) with videos related to
Sort By:
Pageof 32
Cancer|June 12, 2009
Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phaseYesid Alvarado, Hagop Kantarjian, Susan O'Brien, et al.Blood|October 2, 2008
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patientsMikkael A Sekeres, Paul Elson, Matt E Kalaycio, et al.Cancer|June 22, 2010
Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndromeAmit Lahoti, Hagop Kantarjian, Abdulla K Salahudeen, et al.Cancer|August 30, 2008
Clofarabine combinations as acute myeloid leukemia salvage therapyStefan Faderl, Alessandra Ferrajoli, William Wierda, et al.Cancer|December 13, 2005
Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapyGautam Borthakur, Hagop Kantarjian, George Daley, et al.Cancer|July 29, 2010
Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 studyMichael Rytting, Farhad Ravandi, Elihu Estey, et al.Blood|June 21, 2003
Rituximab in relapsed or refractory hairy cell leukemiaDeborah A Thomas, Susan O'Brien, Carlos Bueso-Ramos, et al.Cancer|July 29, 2015
Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemiaNicholas J Short, Michael J Keating, William G Wierda, et al.American Journal of Hematology|October 21, 2004
Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experienceBryan Hennessy, Francis Giles, Jorge Cortes, et al.Leukemia & Lymphoma|December 19, 2009
Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromesGautam Borthakur, Xuelin Huang, Hagop Kantarjian, et al.Pageof 32